Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

They work by mimicking the action of a hormone called glucagon-like peptide 1 (hence GLP-1), stimulating ... The “trendification” of Ozempic and semaglutide is putting immense pressure on ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...